Results 51 to 60 of about 164,447 (275)

Clinical Relevance of Pharmacogenetics in Serotonin Syndrome

Case Reports in Psychiatry, 2020
Serotonin syndrome is a predictable life-threatening condition that is caused by serotonergic stimulation of the central and peripheral nervous systems.
Dehuti Pandya, My Tran, Monica Verduzco-Gutierrez   +2 more
doaj   +1 more source

5-hydroxytryptamine (5-HT) cellular sequestration during chronic exposure delays 5-HT₃ receptor resensitization due to Its subsequent release [PDF]

, 2014
The serotonergic synapse is dynamically regulated by serotonin (5-hydroxytryptamine (5-HT)) with elevated levels leading to the down-regulation of the serotonin transporter and a variety of 5-HT receptors, including the 5-HT type-3 (5-HT(3)) receptors ...
Aapro, Ahern, Amy Alexander, Andrew J. Samson, Bearcroft, Bertrand, Bertrand, Bhattacharyya, Boyd, Chanrion, Chen, Chen, Christopher Moffat, Christopher N. Connolly, Connolly, Craig, Faerber, Freeman, Galligan, Guthrie, Hagbom, Hanley, Hansen, Hothersall, Huang, Ilegems, J. Daniel Hothersall, Jiménez-Trejo, Karen A. Bollan, Kittler, Kondaurova, Lau, Lee, Linder, Liu, Liu, Lummis, McKinnon, Mercado, Minami, Mnie-Filali, Muchatuta, Niesler, Riad, Rojas, Schlag, Spiller, Stratz, Tao-Cheng, Turvill, Vikenes, Wade, Wesseldijk, Whalen, Yasuda   +54 more
core   +3 more sources

Citalopram-induced Serotonin Syndrome: A Case Report

Kaohsiung Journal of Medical Sciences, 2005
Serotonin syndrome is a disorder resulting from excess stimulation of serotonin and is associated with drug interaction, single-drug therapy, and overdose.
Wu-Pin Tseng, Ming-Tsang Wu, Chia-Tsuan Huang, Hong-Wen Liu   +3 more
doaj   +1 more source

Serotonin Syndrome in Critical Care

Journal of Investigative Medicine High Impact Case Reports, 2023
Serotonin syndrome is a life-threatening syndrome that can occur when medications or drugs that cause serotonergic activity are taken. Frequently this syndrome is caused using 2 serotonergic medications at once or switching from 1 serotonergic medication
Daniel Miller DO, Deesha Shah MD, John Huribal MD, Skye Felice DO, Theo Trandafirescu MD   +4 more
doaj   +1 more source

Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report

Frontiers in Psychiatry, 2023
BackgroundSerotonin syndrome has been recognized as a serious adverse reaction to antidepressants and is characterized by sudden or severe autonomic nerve dysfunction and neuromuscular symptoms.
Jianhong Wu, Jianhong Wu, Jiao Yu, Jiao Yu, Kankan Qu, Kankan Qu, Jiajun Yin, Jiajun Yin, Chunming Zhu, Chunming Zhu, Xiaowei Liu, Xiaowei Liu   +11 more
doaj   +1 more source

Management of Widespread Pain and Fibromyalgia [PDF]

, 2016
Peer reviewedPublisher ...
Basu, Neil, Dean, Linda E, Whibley, Daniel   +2 more
core   +2 more sources

Serotonin syndrome: a rare undiagnosed cause of hyperpyrexia

The Egyptian Journal of Internal Medicine, 2023
Serotonin syndrome (SS) is a rare but potentially life-threatening condition, and it is caused by increasing serotonergic activities. It is an underdiagnosed and under-reported condition.
Hamdy Ibrahim, Safwat Abdel Maksod, Magdy Khorshed, Hanan Rady, Ahmed Alsisi, Adel Mohamed, Omar Alkassas, Marwa Haron, Suzan Saied   +8 more
doaj   +1 more source

Contemporary management of pain in cirrhosis: Toward precision therapy for pain

Hepatology, EarlyView., 2022
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman, Neehar Parikh, Dan J. Clauw, David A. Williams, Elliot B. Tapper   +4 more
wiley   +1 more source

Delayed onset serotonin syndrome in the setting of polypharmacy

Journal of Community Hospital Internal Medicine Perspectives, 2021
Serotonin syndrome is a rare but well-known condition that can be life-threatening if not diagnosed early. Onset is usually within 4 to 13 h of starting the offending medication.
Roshan Acharya, Smita Kafle, Sijan Basnet, DilliRam Poudel, Sushil Ghimire   +4 more
doaj   +1 more source

Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG) [PDF]

, 2017
Osteoporosis-pseudoglioma syndrome (OPPG) is a rare autosomal recessive syndrome characterized by juvenile-onset osteoporosis and ocular abnormalities due to a low-density lipoprotein receptor-related protein 5 (LRP5) gene mutation.
Celli, L, Celli, M., D'Alfonso, Y, D'Eufemia, P, Febbo, A, Persiani, P, Turchetti, A., Zambrano, A   +7 more
core   +1 more source